{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:46:28Z","timestamp":1792791988337,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11154-020-09569-2","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T01:09:43Z","timestamp":1594256983000},"page":"495-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Endocrine and metabolic aspects of the COVID-19 pandemic"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-9618","authenticated-orcid":false,"given":"M\u00f3nica","family":"Marazuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Puig-Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"9569_CR1","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239.","journal-title":"JAMA."},{"key":"9569_CR2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/jcm9020575","volume":"9","author":"S-Q Deng","year":"2020","unstructured":"Deng S-Q, Peng H-J. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9:575.","journal-title":"J Clin Med"},{"key":"9569_CR3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2230-8210.94253","volume":"16","author":"C Alves","year":"2012","unstructured":"Alves C, Casqueiro J, Casqueiro J. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16:27.","journal-title":"Indian J Endocrinol Metab"},{"key":"9569_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2020.03.002","volume":"14","author":"R Gupta","year":"2020","unstructured":"Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14:211\u20132.","journal-title":"Diabetes Metab Syndr"},{"key":"9569_CR5","first-page":"14238","volume":"all","author":"J Zhang","year":"2020","unstructured":"Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;all:14238.","journal-title":"Allergy"},{"key":"9569_CR6","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020;","DOI":"10.1001\/jama.2020.1585"},{"key":"9569_CR7","doi-asserted-by":"crossref","unstructured":"Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;S0140673620306279.","DOI":"10.1016\/S0140-6736(20)30627-9"},{"key":"9569_CR8","doi-asserted-by":"crossref","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O\u2019Donnell LF, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City [internet]. Intensive care and critical care medicine; 2020 Apr. Available from:. http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2020.04.08.20057794.","DOI":"10.1101\/2020.04.08.20057794"},{"key":"9569_CR9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","volume":"43","author":"GP Fadini","year":"2020","unstructured":"Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Investig. 2020;43:867\u20139.","journal-title":"J Endocrinol Investig"},{"key":"9569_CR10","doi-asserted-by":"crossref","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;NEJMoa2002032.","DOI":"10.1101\/2020.02.06.20020974"},{"key":"9569_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol Off J Ger Card Soc. 2020;109:531\u20138.","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"9569_CR12","doi-asserted-by":"crossref","first-page":"111255","DOI":"10.1016\/j.mad.2020.111255","volume":"188","author":"C Leung","year":"2020","unstructured":"Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China. Mech Ageing Dev. 2020;188:111255.","journal-title":"Mech Ageing Dev"},{"key":"9569_CR13","unstructured":"Center for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). [Internet]. Httpswwwcdcgovcoronavirus2019-Ncovhcpclinical-Guid.-Manag.-Patientshtml. 2020 [cited 2020 Apr 3]. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html"},{"key":"9569_CR14","doi-asserted-by":"crossref","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","volume":"55","author":"W Guan","year":"2020","unstructured":"Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55:2000547.","journal-title":"Eur Respir J"},{"key":"9569_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","volume":"68","author":"M Puig-Domingo","year":"2020","unstructured":"Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68:2\u20135.","journal-title":"Endocrine."},{"key":"9569_CR16","doi-asserted-by":"crossref","unstructured":"Hill MA, Mantzoros C, Sowers JR. Commentary: COVID-19 in patients with diabetes. Metabolism. 2020;154217.","DOI":"10.1016\/j.metabol.2020.154217"},{"key":"9569_CR17","volume":"28","author":"ME Morra","year":"2018","unstructured":"Morra ME, Van Thanh L, Kamel MG, Ghazy AA, Altibi AMA, Dat LM, et al. Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis. Rev Med Virol. 2018;28:e1977.","journal-title":"Rev Med Virol"},{"key":"9569_CR18","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1210\/jc.2017-00913","volume":"102","author":"C L\u00f3pez-Cano","year":"2017","unstructured":"L\u00f3pez-Cano C, Lecube A, Garc\u00eda-Ram\u00edrez M, Mu\u00f1oz X, S\u00e1nchez E, Seminario A, et al. Serum surfactant protein D as a biomarker for measuring lung involvement in obese patients with type 2 diabetes. J Clin Endocrinol Metab. 2017;102:4109\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"9569_CR19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/er.2017-00173","volume":"38","author":"A Lecube","year":"2017","unstructured":"Lecube A, Sim\u00f3 R, Pallayova M, Punjabi NM, L\u00f3pez-Cano C, Turino C, et al. Pulmonary function and sleep breathing: two new targets for type 2 diabetes care. Endocr Rev. 2017;38:550\u201373.","journal-title":"Endocr Rev"},{"key":"9569_CR20","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s00134-003-1961-2","volume":"29","author":"BJ Philips","year":"2003","unstructured":"Philips BJ, Meguer J-X, Redman J, Baker EH. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med. 2003;29:2204\u201310.","journal-title":"Intensive Care Med"},{"key":"9569_CR21","doi-asserted-by":"crossref","first-page":"154216","DOI":"10.1016\/j.metabol.2020.154216","volume":"107","author":"J Zhou","year":"2020","unstructured":"Zhou J, Tan J. Diabetes patients with COVID-19 need better blood glucose management in Wuhan. China Metabolism. 2020;107:154216.","journal-title":"China Metabolism"},{"key":"9569_CR22","doi-asserted-by":"crossref","unstructured":"Sardu C, D\u2019Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? Diabetes Care. 2020:dc200723.","DOI":"10.2337\/figshare.12275516"},{"key":"9569_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/381415","volume":"2015","author":"AM Lucas Mart\u00edn","year":"2015","unstructured":"Lucas Mart\u00edn AM, Guanyabens E, Zavala-Arauco R, Chamorro J, Granada ML, Mauricio D, et al. Breaking therapeutic inertia in type 2 diabetes: active detection of in-patient cases allows improvement of metabolic control at midterm. Int J Endocrinol. 2015;2015:1\u20135.","journal-title":"Int J Endocrinol"},{"key":"9569_CR24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.medcli.2009.02.001","volume":"132","author":"A P\u00e9rez P\u00e9rez","year":"2009","unstructured":"P\u00e9rez P\u00e9rez A, Conthe Guti\u00e9rrez P, Aguilar Diosdado M, Bertomeu Mart\u00ednez V, Galdos Anuncibay P, Garc\u00eda de Casasola G, et al. Tratamiento de la hiperglucemia en el hospital. Med Cl\u00ednica. 2009;132:465\u201375.","journal-title":"Med Cl\u00ednica"},{"key":"9569_CR25","doi-asserted-by":"crossref","unstructured":"Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, et al. New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic. Diabet Med. 2020:dme.14327.","DOI":"10.1111\/dme.14327"},{"key":"9569_CR26","unstructured":"Cranston, Nicholson, Meeking, Butt, Kar, Cummings. Urgent Safety Notice: Use of SGLT2 inhibitors during the Covid-19 Crisis. R United Hosp Bath NHS Found Trust. 2020 Apr 3;"},{"key":"9569_CR27","doi-asserted-by":"crossref","unstructured":"Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020.","DOI":"10.1111\/dom.14057"},{"key":"9569_CR28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","volume":"8","author":"SR Bornstein","year":"2020","unstructured":"Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8:546\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9569_CR29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DHW, M\u00fcller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251\u20134.","journal-title":"Nature."},{"key":"9569_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2016.02.014","volume":"426","author":"MT Juli\u00e1n","year":"2016","unstructured":"Juli\u00e1n MT, Alonso N, Colobran R, S\u00e1nchez A, Mi\u00f1arro A, Pujol-Autonell I, et al. CD26\/DPPIV inhibition alters the expression of immune response-related genes in the thymi of NOD mice. Mol Cell Endocrinol. 2016;426:101\u201312.","journal-title":"Mol Cell Endocrinol"},{"key":"9569_CR31","doi-asserted-by":"crossref","first-page":"E3119","DOI":"10.1073\/pnas.1619109114","volume":"114","author":"K Li","year":"2017","unstructured":"Li K, Wohlford-Lenane CL, Channappanavar R, Park J-E, Earnest JT, Bair TB, et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A. 2017;114:E3119\u201328.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9569_CR32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020;9:601\u20134.","journal-title":"Emerg Microbes Infect"},{"key":"9569_CR33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","volume":"500","author":"G Lu","year":"2013","unstructured":"Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013;500:227\u201331.","journal-title":"Nature."},{"key":"9569_CR34","doi-asserted-by":"crossref","unstructured":"Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA [Internet]. 2020 [cited 2020 Apr 9]; Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2763667","DOI":"10.1001\/jama.2020.4683"},{"key":"9569_CR35","doi-asserted-by":"crossref","unstructured":"Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity [Internet]. 2020 [cited 2020 Apr 9]; Available from: http:\/\/doi.wiley.com\/10.1002\/oby.22818","DOI":"10.1002\/oby.22818"},{"key":"9569_CR36","doi-asserted-by":"crossref","unstructured":"Qingxian C, Fengjuan C, Fang L, Xiaohui L, Tao W, Qikai W, et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. SSRN Electron J [Internet]. 2020 [cited 2020 May 21]; Available from: https:\/\/www.ssrn.com\/abstract=3556658","DOI":"10.2139\/ssrn.3556658"},{"key":"9569_CR37","unstructured":"ICNARC \u2013 Intensive Care National Audit & Research Centre [Internet]. [cited 2020 May 21]. Available from: https:\/\/www.icnarc.org\/"},{"key":"9569_CR38","doi-asserted-by":"crossref","unstructured":"Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity [Internet]. 2020 [cited 2020 Apr 11]; Available from: http:\/\/doi.wiley.com\/10.1002\/oby.22831","DOI":"10.1002\/oby.22831"},{"key":"9569_CR39","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4065\/mcp.2010.0166","volume":"85","author":"C Venkata","year":"2010","unstructured":"Venkata C, Sampathkumar P, Afessa B. Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. Mayo Clin Proc. 2010;85:798\u2013805.","journal-title":"Mayo Clin Proc"},{"key":"9569_CR40","doi-asserted-by":"crossref","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D A. MPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;","DOI":"10.1016\/j.thromres.2020.04.013"},{"key":"9569_CR41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/obr.12320","volume":"16","author":"NV Dhurandhar","year":"2015","unstructured":"Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections: interaction of obesity and infections. Obes Rev. 2015;16:1017\u201329.","journal-title":"Obes Rev"},{"key":"9569_CR42","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/cmi.12336","volume":"16","author":"VJ Vieira-Potter","year":"2014","unstructured":"Vieira-Potter VJ. Inflammation and macrophage modulation in adipose tissues: adipose tissue macrophage modulation. Cell Microbiol. 2014;16:1484\u201392.","journal-title":"Cell Microbiol"},{"key":"9569_CR43","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/JOE-14-0283","volume":"222","author":"M Mraz","year":"2014","unstructured":"Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222:R113\u201327.","journal-title":"J Endocrinol"},{"key":"9569_CR44","doi-asserted-by":"crossref","unstructured":"Sattar N, McInnes IB, McMurray JJV. Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020.","DOI":"10.1161\/CIRCULATIONAHA.120.047659"},{"key":"9569_CR45","doi-asserted-by":"crossref","unstructured":"Honce R, Karlsson EA, Wohlgemuth N, Estrada LD, Meliopoulos VA, Yao J, et al. Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains. Moscona A, editor. mBio. 2020;11:e03341\u201319, \/mbio\/11\/2\/mBio.03341\u201319.atom.","DOI":"10.1128\/mBio.03341-19"},{"key":"9569_CR46","doi-asserted-by":"crossref","first-page":"154251","DOI":"10.1016\/j.metabol.2020.154251","volume":"108","author":"G Muscogiuri","year":"2020","unstructured":"Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A. Comentary: obesity: the \u201cAchilles heel\u201d for COVID-19? Metabolism. 2020;108:154251.","journal-title":"Metabolism."},{"key":"9569_CR47","first-page":"4","volume":"7","author":"Y-H Jin","year":"2020","unstructured":"Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4.","journal-title":"Mil Med Res"},{"key":"9569_CR48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2018-01414","volume":"104","author":"A Giustina","year":"2019","unstructured":"Giustina A, Adler RA, Binkley N, Bouillon R, Ebeling PR, Lazaretti-Castro M, et al. Controversies in Vitamin D: summary statement from an international conference. J Clin Endocrinol Metab. 2019;104:234\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"9569_CR49","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","volume":"40","author":"R Bouillon","year":"2019","unstructured":"Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, et al. Skeletal and Extraskeletal actions of Vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40:1109\u201351.","journal-title":"Endocr Rev"},{"key":"9569_CR50","doi-asserted-by":"crossref","first-page":"i6583","DOI":"10.1136\/bmj.i6583","volume":"356","author":"AR Martineau","year":"2017","unstructured":"Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.","journal-title":"BMJ."},{"key":"9569_CR51","doi-asserted-by":"crossref","unstructured":"Christopher KB. Vitamin D and critical illness outcomes: Curr Opin Crit Care. 2016;22:332\u20138.","DOI":"10.1097\/MCC.0000000000000328"},{"key":"9569_CR52","volume-title":"Re: preventing a covid-19 pandemic can high prevalence of severe hypovitaminosis D play a role in the high impact of Covid infection in Italy? BMJ march 20","author":"A Giustina","year":"2020","unstructured":"Giustina A, Formenti AM Re: preventing a covid-19 pandemic can high prevalence of severe hypovitaminosis D play a role in the high impact of Covid infection in Italy? BMJ march 20 2020 https:\/\/www.bmj.com\/content\/368\/bmj.m810\/rr-36"},{"issue":"10","key":"9569_CR53","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/bcp.13652","volume":"84","author":"CT Sempos","year":"2018","unstructured":"Sempos CT, Heijboer AC, Bikle DD, Bollerslev J, Bouillon R, Brannon PM, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in Vitamin D. Br J Clin Pharmacol. 2018;84(10):2194\u2013207. https:\/\/doi.org\/10.1111\/bcp.13652.","journal-title":"Br J Clin Pharmacol"},{"key":"9569_CR54","doi-asserted-by":"crossref","unstructured":"Ebeling PR, Adler RA, Jones G, Liberman UA, Mazziotti G, Minisola S, et al. MANAGEMENT OF ENDOCRINE DISEASE: therapeutics of vitamin D. Eur J Endocrinol. 2018:R239\u201359.","DOI":"10.1530\/EJE-18-0151"},{"issue":"1","key":"9569_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11154-019-09532-w","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, et al. Consensus statement from 2nd international conference on controversies in Vitamin D. Rev Endocr Metab Disord. 2020;21(1):89\u2013116. https:\/\/doi.org\/10.1007\/s11154-019-09532-w.","journal-title":"Rev Endocr Metab Disord"},{"key":"9569_CR56","doi-asserted-by":"publisher","unstructured":"Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome? [published online ahead of print, 2020 May 20]. Lancet Diabetes Endocrinol. 2020;S2213\u20138587(20)30183\u20132. https:\/\/doi.org\/10.1016\/S2213-8587(20)30183-2","DOI":"10.1016\/S2213-8587(20)30183-2"},{"key":"9569_CR57","unstructured":"Rubel AR, Chong PL, Abdullah MS, Asli R, Momin RN, Mani BI, et al. Letter to the Editor: Lipemic serum in patients with COVID-19 undergoing treatment. J Med Virol. 2020;jmv.25942."},{"key":"9569_CR58","doi-asserted-by":"crossref","unstructured":"Morrison AR, Johnson JM, Ramesh M, Bradley P, Jennings J, Smith ZR. Letter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab. J Med Virol. 2020;jmv.25907.","DOI":"10.1002\/jmv.25907"},{"key":"9569_CR59","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/jac\/dki063","volume":"55","author":"ML Montes","year":"2005","unstructured":"Montes ML, Pulido F, Barros C, Condes E, Rubio R, Cepeda C, et al. Lipid disorders in antiretroviral-naive patients treated with lopinavir\/ritonavir-based HAART: frequency, characterization and risk factors. J Antimicrob Chemother. 2005;55:800\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"9569_CR60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.41095","volume":"72","author":"JT Giles","year":"2020","unstructured":"Giles JT, Sattar N, Gabriel S, Ridker PM, Gay S, Warne C, et al. Cardiovascular safety of Tocilizumab versus Etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol Hoboken NJ. 2020;72:31\u201340.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"9569_CR61","doi-asserted-by":"crossref","unstructured":"Castiglione V, Chiriac\u00f2 M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur Heart J - Cardiovasc Pharmacother. 2020;pvaa042.","DOI":"10.1093\/ehjcvp\/pvaa042"},{"key":"9569_CR62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.12902","volume":"154","author":"R Zeiser","year":"2018","unstructured":"Zeiser R. Immune modulatory effects of statins. Immunology. 2018;154:69\u201375.","journal-title":"Immunology."},{"key":"9569_CR63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","volume":"99","author":"DS Fedson","year":"2013","unstructured":"Fedson DS. Treating influenza with statins and other immunomodulatory agents. Antivir Res. 2013;99:417\u201335.","journal-title":"Antivir Res"},{"key":"9569_CR64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","volume":"63","author":"MK-S Leow","year":"2005","unstructured":"Leow MK-S, Kwek DS-K, Ng AW-K, Ong K-C, Kaw GJ-L, Lee LS-U. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol. 2005;63:197\u2013202.","journal-title":"Clin Endocrinol"},{"key":"9569_CR65","doi-asserted-by":"crossref","unstructured":"Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest [Internet]. 2020 [cited 2020 May 21]; Available from: http:\/\/link.springer.com\/10.1007\/s40618-020-01276-8","DOI":"10.1007\/s40618-020-01276-8"},{"issue":"9","key":"9569_CR66","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.tem.2019.06.004","volume":"30","author":"S Chiloiro","year":"2019","unstructured":"Chiloiro S, Capoluongo ED, Tartaglione T, Giampietro A, Bianchi A, Giustina A, et al. The changing clinical Spectrum of Hypophysitis. Trends Endocrinol Metab. 2019;30(9):590\u2013602. https:\/\/doi.org\/10.1016\/j.tem.2019.06.004.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"9569_CR67","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, et al. A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018;14(9):552\u201361. https:\/\/doi.org\/10.1038\/s41574-018-0058-5.","journal-title":"Nat Rev Endocrinol"},{"key":"9569_CR68","unstructured":"Fleseriu M, Karavitaki N, Dekkers OM. Endocrinology in the time of COVID-19: Management of pituitary tumours. Eur J Endocrinol [Internet]. 2020 [cited 2020 May 21]; Available from: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/aop\/eje-20-0473\/eje-20-0473.xml"},{"key":"9569_CR69","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","volume":"382","author":"PK Bhatraju","year":"2020","unstructured":"Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382:2012\u201322.","journal-title":"N Engl J Med"},{"key":"9569_CR70","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1530\/EJE-20-0338","volume":"183","author":"M Christ Crain","year":"2020","unstructured":"Christ Crain M, Hoorn EJ, Sherlock M, Thompson CJ, Wass JAH. Endocrinology in the time of COVID-19: management of Hyponatraemia and diabetes Insipidus. Eur J Endocrinol. 2020;183:G9\u2013G15.","journal-title":"Eur J Endocrinol"},{"key":"9569_CR71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2006.06.011","volume":"38","author":"L Wei","year":"2007","unstructured":"Wei L, Sun S, Xu C-H, Zhang J, Xu Y, Zhu H, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38:95\u2013102.","journal-title":"Hum Pathol"},{"key":"9569_CR72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/eje.0.1440221","volume":"144","author":"FE De Jongh","year":"2001","unstructured":"De Jongh FE, J\u00f6bsis AC, Elte JW. Thyroid morphology in lethal non-thyroidal illness: a post-mortem study. Eur J Endocrinol. 2001;144:221\u20136.","journal-title":"Eur J Endocrinol"},{"key":"9569_CR73","doi-asserted-by":"publisher","unstructured":"Vrachimis A, Iacovou I, Giannoula E, Giovanella L. Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer [published online ahead of print, 2020 May 1]. Eur J Endocrinol. 2020;EJE-20-0269.R2. https:\/\/doi.org\/10.1530\/EJE-20-0269","DOI":"10.1530\/EJE-20-0269"},{"issue":"5","key":"9569_CR74","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2967\/jnumed.120.246256","volume":"61","author":"D Albano","year":"2020","unstructured":"Albano D, Bertagna F, Bertoli M, Bosio G, Lucchini S, Motta F, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med. 2020;61(5):632\u20136. https:\/\/doi.org\/10.2967\/jnumed.120.246256.","journal-title":"J Nucl Med"},{"key":"9569_CR75","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-16-0969","volume":"176","author":"I Bancos","year":"2017","unstructured":"Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, Lord JM, et al. Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol. 2017;176:471\u201380.","journal-title":"Eur J Endocrinol"},{"key":"9569_CR76","doi-asserted-by":"crossref","unstructured":"Arlt W, Baldeweg SE, Pearce SHS, Simpson HL. Endocrinology in the time of COVID-19: management of adrenal insufficiency. Eur J Endocrinol. 2020.","DOI":"10.1530\/EJE-20-0361"},{"key":"9569_CR77","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.mehy.2004.04.009","volume":"63","author":"R Wheatland","year":"2004","unstructured":"Wheatland R. Molecular mimicry of ACTH in SARS - implications for corticosteroid treatment and prophylaxis. Med Hypotheses. 2004;63:855\u201362.","journal-title":"Med Hypotheses"},{"key":"9569_CR78","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EC-16-0054","volume":"5","author":"W Arlt","year":"2016","unstructured":"Arlt W. __. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr Connect. 2016;5:G1\u20133.","journal-title":"Endocr Connect"},{"key":"9569_CR79","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1530\/EJE-17-0154","volume":"177","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, et al. MANAGEMENT OF ENDOCRINE DISEASE: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol. 2017;177:R231\u201348.","journal-title":"Eur J Endocrinol"},{"key":"9569_CR80","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-15-0608","volume":"173","author":"CP Woods","year":"2015","unstructured":"Woods CP, Argese N, Chapman M, Boot C, Webster R, Dabhi V, et al. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. Eur J Endocrinol. 2015;173:633\u201342.","journal-title":"Eur J Endocrinol"},{"key":"9569_CR81","unstructured":"Newell-Price J, Nieman L, Reincke M, Tabarin A. Endocrinology in the time of COVID-19: Management of Cushing\u2019s syndrome. Eur J Endocrinol [Internet]. 2020 [cited 2020 May 21]; Available from: https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/aop\/eje-20-0352\/eje-20-0352.xml"},{"key":"9569_CR82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.virol.2017.12.015","volume":"517","author":"JK Millet","year":"2018","unstructured":"Millet JK, Whittaker GR. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology. 2018 Apr;517:3\u20138.","journal-title":"Virology."},{"key":"9569_CR83","doi-asserted-by":"crossref","unstructured":"Straus MR, et al. Ca2+ ions promote fusion of Middle East respiratory syndrome coronavirus with host cells and increase infectivity. J Virol. 2020 Apr;15.","DOI":"10.1101\/2019.12.18.881391"},{"issue":"2","key":"9569_CR84","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/acsinfecdis.9b00296","volume":"6","author":"L Nathan","year":"2020","unstructured":"Nathan L, Lai AL, Millet JK, Straus MR, Freed JH, Whittaker GR, et al. Calcium ions directly interact with the Ebola virus fusion peptide to promote structure-function changes that enhance infection. ACS Infect Dis. 2020 Feb 14;6(2):250\u201360.","journal-title":"ACS Infect Dis"},{"key":"9569_CR85","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1001\/jama.289.21.JOC30885","volume":"289","author":"CM Booth","year":"2003","unstructured":"Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801\u20139.","journal-title":"JAMA."},{"key":"9569_CR86","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMoa1504874","volume":"374","author":"TM Uyeki","year":"2016","unstructured":"Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, et al. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med. 2016;374:636\u201346.","journal-title":"N Engl J Med"},{"key":"9569_CR87","doi-asserted-by":"crossref","unstructured":"Bossoni S, Chiesa L, Giustina A. Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection. Endocrine [Internet]. 2020 [cited 2020 May 21]; Available from: http:\/\/link.springer.com\/10.1007\/s12020-020-02326-0","DOI":"10.1007\/s12020-020-02326-0"},{"key":"9569_CR88","unstructured":"Di Filippo L, Formenti AM, Rovere-Querini P, Carlucci M Conte C, Ciceri F, Zangrillo A, Giustina A. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 Endocrine [in press]."},{"key":"9569_CR89","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.beem.2018.12.002","volume":"32","author":"F Tecilazich","year":"2018","unstructured":"Tecilazich F, Formenti AM, Frara S, Giubbini R, Giustina A. Treatment of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32:955\u201364.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9569_CR90","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12020-019-02105-6","volume":"66","author":"AM Formenti","year":"2019","unstructured":"Formenti AM, Tecilazich F, Frara S, Giubbini R, De Luca H, Giustina A. Body mass index predicts resistance to active vitamin D in patients with hypoparathyroidism. Endocrine. 2019;66:699\u2013700.","journal-title":"Endocrine."},{"key":"9569_CR91","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl. 2020;395:507\u201313.","journal-title":"Lancet Lond Engl"},{"key":"9569_CR92","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. J Immunol Baltim Md 1950. 2017;198:4046\u201353.","DOI":"10.4049\/jimmunol.1601896"},{"key":"9569_CR93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.e8.","journal-title":"Cell."},{"key":"9569_CR94","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","volume":"4","author":"JM Lucas","year":"2014","unstructured":"Lucas JM, Heinlein C, Kim T, Hernandez SA, Malik MS, True LD, et al. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discov. 2014;4:1310\u201325.","journal-title":"Cancer Discov"},{"key":"9569_CR95","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate Cancer. Science. 2005;310:644\u20138.","journal-title":"Science."},{"key":"9569_CR96","doi-asserted-by":"crossref","unstructured":"Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention? Cancer Discov. 2020;candisc;2159\u20138290.CD-20-0451v3.","DOI":"10.1158\/2159-8290.CD-20-0451"},{"key":"9569_CR97","doi-asserted-by":"crossref","unstructured":"Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is there an association between COVID-19 mortality and the renin-angiotensin system-a call for epidemiologic investigations. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020.","DOI":"10.1093\/cid\/ciaa329"},{"key":"9569_CR98","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u20134.","journal-title":"Nature."},{"key":"9569_CR99","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00059-020-04909-z","volume":"45","author":"C Chen","year":"2020","unstructured":"Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45:230\u20132.","journal-title":"Herz."},{"key":"9569_CR100","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605\u201310.","journal-title":"Circulation."},{"key":"9569_CR101","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.","journal-title":"Lancet Respir Med"},{"key":"9569_CR102","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653\u20139.","journal-title":"N Engl J Med"},{"key":"9569_CR103","doi-asserted-by":"crossref","unstructured":"Sommerstein R, Kochen MM, Messerli FH, Gr\u00e4ni C. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers Have a Biphasic Effect? J Am Heart Assoc [Internet]. 2020 [cited 2020 May 21];9. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.120.016509","DOI":"10.1161\/JAHA.120.016509"},{"key":"9569_CR104","doi-asserted-by":"crossref","unstructured":"Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020.","DOI":"10.1002\/ddr.21656"},{"key":"9569_CR105","unstructured":"Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol [Internet]. 2020 [cited 2020 Apr 12]; Available from: http:\/\/www.nature.com\/articles\/s41574-020-0353-9"},{"key":"9569_CR106","doi-asserted-by":"crossref","first-page":"109785","DOI":"10.1016\/j.mehy.2020.109785","volume":"140","author":"A Soumier","year":"2020","unstructured":"Soumier A, Sirigu A. Oxytocin as a potential defence against Covid-19? Med Hypotheses. 2020;140:109785.","journal-title":"Med Hypotheses"},{"key":"9569_CR107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jneuroim.2015.11.001","volume":"289","author":"P Wang","year":"2015","unstructured":"Wang P, Yang H-P, Tian S, Wang L, Wang SC, Zhang F, et al. Oxytocin-secreting system: a major part of the neuroendocrine center regulating immunologic activity. J Neuroimmunol. 2015;289:152\u201361.","journal-title":"J Neuroimmunol"},{"key":"9569_CR108","doi-asserted-by":"crossref","unstructured":"Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020:1\u201310.","DOI":"10.20944\/preprints202004.0122.v2"},{"key":"9569_CR109","doi-asserted-by":"crossref","unstructured":"Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;117583.","DOI":"10.1016\/j.lfs.2020.117583"}],"updated-by":[{"DOI":"10.1007\/s11154-020-09620-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000}}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-020-09569-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T18:22:30Z","timestamp":1696357350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-020-09569-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9569"],"URL":"https:\/\/doi.org\/10.1007\/s11154-020-09569-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11154-020-09620-2","asserted-by":"object"}]},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"9 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published: <ExternalRef><RefSource>https:\/\/doi.org\/10.1007\/s11154-020-09620-2<\/RefSource><RefTarget Address=\"10.1007\/s11154-020-09620-2\" TargetType=\"DOI\"\/><\/ExternalRef>","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no competing financial interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}